Lei Geraldine Yanlei, Shen Liang, Junnarkar Sameer P, Huey CheongWei Terence, Low JeeKeem, Shelat Vishal G
Department of General Surgery, Ministry of Health Holdings, Singapore, Singapore.
Department of Biostatistics Unit, National University Health System, Singapore, Singapore.
Visc Med. 2021 Mar;37(2):102-109. doi: 10.1159/000510811. Epub 2020 Oct 27.
BACKGROUND/PURPOSE: 90-day mortality is a key performance indicator for short-term perioperative outcome of hepatic resection (HR). Although many preoperative, intraoperative, and postoperative variables predict 90-day mortality following elective HR, only few are specific to hepatocellular carcinoma (HCC). This study aims to determine the predictors of 90-day mortality following elective HR for HCC.
We report a retrospective analysis of patients who underwent elective HR between January 1, 2007, and December 31, 2017. Health status, perioperative variables, and the presence of post-hepatectomy liver failure (PHLF) were studied. Cox's regression evaluated factors predicting 90-day mortality.
Two hundred and forty-four patients diagnosed with HCC underwent HR; 102 (41.8%) underwent a major HR. The postoperative 90-day mortality rate was 5.3%. Multivariate analysis demonstrated that Child-Pugh score ( < 0.001), intraoperative blood loss ( = 0.013), the 50-50 criteria for PHLF ( < 0.001) on postoperative day 5, and peak serum bilirubin >119 µmol/L ( = 0.007) on postoperative day 3 predict 90-day mortality.
In patients with HCC undergoing HR, Child-Pugh score, intraoperative blood loss, the 50-50 criteria for PHLF on postoperative day 5, and peak serum bilirubin >119 µmol/L on postoperative day 3 predict 90-day mortality following elective HR for HCC.
背景/目的:90天死亡率是肝切除(HR)围手术期短期结局的关键性能指标。尽管许多术前、术中和术后变量可预测择期HR后的90天死亡率,但只有少数变量是肝细胞癌(HCC)特有的。本研究旨在确定HCC择期HR后90天死亡率的预测因素。
我们报告了对2007年1月1日至2017年12月31日期间接受择期HR的患者的回顾性分析。研究了健康状况、围手术期变量以及肝切除术后肝衰竭(PHLF)的存在情况。Cox回归评估了预测90天死亡率的因素。
244例诊断为HCC的患者接受了HR;102例(41.8%)接受了大肝切除。术后90天死亡率为5.3%。多变量分析表明,Child-Pugh评分(<0.001)、术中失血量(=0.013)、术后第5天的PHLF 50-50标准(<0.001)以及术后第3天血清胆红素峰值>119 µmol/L(=0.007)可预测90天死亡率。
在接受HR的HCC患者中,Child-Pugh评分、术中失血量、术后第5天的PHLF 50-50标准以及术后第3天血清胆红素峰值>119 µmol/L可预测HCC择期HR后的90天死亡率。